Upper respiratory infection
Conditions
Interventions
Control group:Qingfei Dayuan granule simulant
Experimental group:Qingfei Dayuan particles
Sponsors
Hubei Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Meet the clinical diagnostic criteria for influenza or the diagnostic criteria for acute upper respiratory tract infection; 2. Comply with the standard of TCM heat-toxin attacking the lung syndrome; 3. Aged 18-70 years; 4. Fever duration =37.3?; 5. The informed consent process complies with the regulations, and the informed consent form is signed.
Exclusion criteria
Exclusion criteria: 1. Severe or critical cases of influenza, or diagnosed as novel coronavirus pneumonia, pharyngeal conjunctival fever, herpetic angina, suppurative tonsillitis, etc.; 2. Complications of influenza such as sinusitis, otitis media and pneumonia have occurred; 3. The anti-influenza virus drugs included in the ''Influenza Diagnosis and Treatment Program (2020 Edition)'' have been used within 48 hours before the visit; 4. Systemically receiving steroid therapy or other immunosuppressive therapy; 5. Have a history of epilepsy or febrile convulsions; 6. Patients with severe malnutrition, rickets and serious primary diseases of the heart, brain, liver, kidney and hematopoietic system; 7. Pregnant or breastfeeding patients, allergic constitution, allergic to multiple drugs or allergic to known components of the research drug; 8. According to the judgment of the investigator, other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as unstable living environment, inconvenient transportation, etc., are likely to cause loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time for complete reduction of fever; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of complications and weight loss;Rate of disappearance of individual symptoms and time required for disappearance or remission;TCM syndrome effect;Viral antigen negative conversion rate;Blood routine examination; | — |
Countries
China
Contacts
Public ContactBa Yuanming
Outcome results
None listed